Ono Takayuki, Kobayashi Junjiro, Sasako Yoshikado, Bando K o, Tagusari Osamu, Niwaya Kazuo, Imanaka Hideaki, Nakatani Takeshi, Kitamura Soichiro
Department of Cardiovascular Surgery, National Cardiovascular Center, Osaka, Japan.
J Am Coll Cardiol. 2002 Aug 7;40(3):428-36. doi: 10.1016/s0735-1097(02)01983-6.
We sought to assess the impact of diabetic retinopathy on long-term outcome among patients with diabetes and multivessel coronary artery disease (MVD) following coronary artery bypass graft surgery (CABG).
For diabetics, CABG is the preferred revascularization strategy. Diabetic retinopathy is a major microvascular complication of diabetes, and its severity is directly related to total glycemic exposure.
We identified 223 consecutive diabetics with MVD whose retinae were evaluated within one year prior to CABG. The most recent ophthalmologic records up until the time of CABG were used to evaluate the severity of retinopathy. The median follow-up after CABG was 11.6 years.
Diabetic retinopathy was a strong independent predictor of overall mortality (relative risk [RR], 4.0), and repeat revascularization (RR, 3.0). In separate analyses of diabetics with retinopathy and without retinopathy, predictors of mortality differed significantly between the two groups. Among diabetics with retinopathy, the presence of either preoperative renal (RR, 2.5) or ventricular (RR, 2.0) dysfunction had unfavorable effects on mortality, but the survival curves did not differ significantly according to the presence or absence of internal thoracic artery (ITA) grafting. In comparison, among diabetics without retinopathy, ITA grafting (RR, 0.34) had a beneficial effect on mortality, and the survival curves varied somewhat according to the presence or absence of renal or ventricular dysfunction.
Diabetics with retinopathy had a distinct post-CABG course with a worse long-term prognosis, as compared with diabetics without retinopathy. Retina evaluation is useful for prediction of long-term prognosis and management of diabetics who need CABG.
我们旨在评估糖尿病视网膜病变对糖尿病合并多支冠状动脉疾病(MVD)患者冠状动脉旁路移植术(CABG)后长期预后的影响。
对于糖尿病患者,CABG是首选的血运重建策略。糖尿病视网膜病变是糖尿病的主要微血管并发症,其严重程度与总的血糖暴露直接相关。
我们纳入了223例连续性的患有MVD的糖尿病患者,这些患者在CABG术前一年内接受了视网膜评估。直至CABG手术时的最新眼科记录用于评估视网膜病变的严重程度。CABG术后的中位随访时间为11.6年。
糖尿病视网膜病变是总体死亡率(相对风险[RR],4.0)和再次血运重建(RR,3.0)的强有力独立预测因素。在对有视网膜病变和无视网膜病变的糖尿病患者进行的单独分析中,两组的死亡率预测因素有显著差异。在有视网膜病变的糖尿病患者中,术前存在肾脏(RR,2.5)或心室(RR,2.0)功能障碍对死亡率有不利影响,但生存曲线根据是否使用胸廓内动脉(ITA)移植并无显著差异。相比之下,在无视网膜病变的糖尿病患者中,ITA移植(RR,0.34)对死亡率有有益影响,生存曲线根据是否存在肾脏或心室功能障碍略有不同。
与无视网膜病变的糖尿病患者相比,有视网膜病变的糖尿病患者CABG术后病程独特,长期预后更差。视网膜评估对于预测需要CABG的糖尿病患者的长期预后和管理很有用。